Delivery Order SPE2DR25D3004-SPE2DR26FXST9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,388.84 to supply Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 19, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,995.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This non-set-aside contract, which will be completed by January 7, 2026, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 on December 16, 2025. This firm fixed price delivery order, valued at $2,776.22, is scheduled for completion by December 17, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was made competitively. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,995.68 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 4, 2025. The award was issued on December 3, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules (100-count packages) with a ceiling value of $1,890.00. This firm fixed-price delivery order is set to be completed by December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award with no set-aside designation, issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,991.36 to AmerisourceBergen Drug Corp for oseltamivir phosphate 75 mg capsules in unit-dose packages of 10, with an ultimate completion date of January 6, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,081.00 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s) on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10, with a contract ceiling value of $3,235.68 and ultimate completion date of December 23, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through open competition to the prime contractor. The place of performance is AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s, with a ceiling value of $2,820.63 and an ultimate completion date of December 18, 2025. This is a firm fixed-price, non-set-aside delivery order performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXST9Delivery Order
The Defense Logistics Agency awarded a $2,109.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for oseltamivir phosphate 75 mg capsules in unit dose packaging on January 6, 2026, with completion scheduled for January 7, 2026. This award is a non-set-aside competitive contract performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. This contract represents a routine pharmaceutical supply delivery within DLA's medical supply chain operations supporting Department of Defense healthcare requirements. AmerisourceBergen, as a major pharmaceutical distributor, regularly fulfills such delivery orders for medications across multiple therapeutic domains including antivirals, specialty medications, and generic drugs. The oseltamivir phosphate delivery supports antiviral stockpiling and medical readiness needs for military treatment facilities and defense healthcare systems. The compressed timeline between award and completion dates reflects the urgent nature of pharmaceutical supply requests within the federal medical logistics system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/5/26 |